KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT
The win reflects Kaneka Ubiquinol's outstanding efforts in shining the spotlight on the role of mitochondrial health powered by Ubiquinol, in supporting optimal wellbeing. The award celebrates the strategic impact, scientific credibility and executional excellence of its multi-channel marketing programs which have worked to reach, engage and build trust with brandholders, healthcare professionals, pharmacists, media and consumers alike. As a result this has helped position mitochondrial health and Ubiquinol as the new frontier of evidence-based wellbeing.
Mitochondria, powered by the naturally occurring antioxidant ubiquinol, are the millions of "powerhouses" found in all cells that generate energy in our body. They are found in the largest concentrations in tissues and organs requiring the highest levels of energy production – heart, brain, liver, lungs, muscles, sperm and ovum. Science shows that from the age of approximately 30 + natural Ubiquinol levels start to decline, which may require supplementation.
Kaneka Ubiquinol's unique globally patented precision yeast fermentation process enables the production of bioidentical Ubiquinol, delivering a premium, clinically proven ingredient that supports mitochondrial health.
Upon receiving the award Tsuyoshi Takakuwa, Head of Marketing & Sales (APAC) Supplemental Nutrition Business Division, Kaneka Corporation, Japan said "this recognition reflects the collective efforts of our marketing, science, R&D teams, healthcare practitioner partners, brandholders, KOLs and, importantly consumers, united by a shared commitment to science, quality, education and a long-term vision to cement Ubiquinol's role as the foundation of mitochondrial health."
On congratulating the team, Kazuki Takita, Oceania & Asia Marketing & Sales Team, Supplement Business Group, Supplement Strategic Unit, added that the award is a powerful testament of the success of the brand's multi-market, multi-channel strategy, which supports Kaneka Ubiquinol's presence and credibility across the APAC region.
"This award illustrates our strategic vision: to position Kaneka Ubiquinol™ as a trusted ingredient for healthcare professionals, a premium asset for brandholders, and a clinically supported ingredient for consumers seeking high-quality, evidence-based supplementation to support their overall health and wellbeing," he continued.
"Thank you to NHPNZ and the judging panel for this honour and we extend our congratulations to all the other finalists and winners."
ABOUT KANEKA UBIQUINOL™
Kaneka Ubiquinol™ is supported by 100+ scientific studies, 80+ patents and 45+ years of research, with applications spanning mitochondrial health, cardiovascular health, cognitive function, women's health, reproductive health, energy production, sleep, stress, healthy ageing and vitality.
Kaneka Ubiquinol's impeccable standards are built on the Japanese philosophy of 'Kaizen' meaning 'a commitment to quality, efficiency and pursuit of perfection', from the company's rigorous commitment to quality and research, to their outstanding stakeholder support. Its strict adherence to the highest manufacturing standards guarantees a stable ingredient, free from impurities, meeting rigorous standards and sustainability requirements, setting the global benchmark for production quality. Listed in over 50 countries in 1000+ practitioner and OTC nutraceutical brands since 2006.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
4 hours ago
- Korea Herald
Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense
SAN CLEMENTE, Calif., Aug. 21, 2025 /PRNewswire/ -- Angelalign Technology Inc. ( ("Angel") categorically denies accusations of patent infringement by Align Technology Inc. (ALGN) and promises a vigorous defense. "Angel has a rich heritage of clinically driven innovation during its 20-plus year history. Accusations by our competitor of patent violations are frivolous and entirely without merit," said Angel's Chief Commercial Officer and SVP, Rich Hirschland. "Angel has invested heavily in patent compliance since our founding. We are confident that we will prevail in this case." Angel has proudly led the clear-aligner field in innovation for many years. Among its cutting-edge products are the award-winning angelButton™, the angelHook, the A6 mandibular advancement system (now celebrating its ten-year anniversary), the angelKid system, and the Intelligent Root System. The company is committed to bringing fair and healthy competition to the marketplace to benefit doctors and their patients. Angel's products regularly receive high doctor-satisfaction scores. Its flexible manufacturing system also has been widely praised for turning complex clinical ideas into workable solutions. These innovations, powered by a corporate culture that focuses on treating employees and customers well, have led to impressive global growth for Angel, which is expected to continue. "We anticipate that our growth will not be materially affected by the lawsuits," Hirschland said. "We look forward to using the lawsuits to tell the Angel success story and help attract more customers to Angel around the world." About Angelalign Technology Inc. Founded in 2003 and celebrating 1.5 million smiles, Angelalign Technology Inc. provides digital technology-driven clear aligner products and services to meet the needs of dental professionals and patients worldwide. The Company's innovative products and technical services have established it as a prominent player in the orthodontics industry. In 2021, Angelalign Technology was listed on the Hong Kong Stock Exchange. In 2023, the Company launched its global expansion strategy, with its products and services now reaching over 50 countries and regions. Learn more at
Korea Herald
5 hours ago
- Korea Herald
Galbot Clinches Gold Medal at World Humanoid Robot Games, Redefining Autonomous Robotics in Real-World Applications
BEIJING, Aug. 21, 2025 /PRNewswire/ -- Galbot has made history at the inaugural World Humanoid Robot Games, securing the gold medal in the Robot Skills Competition, with a standout performance in the Pharmaceutical Sorting Challenge. This marks the first time that robot productivity has been showcased on a global stage in a world-class competition, and Galbot has emerged victorious with a commanding performance that sets a new benchmark in autonomous robotics. At the Robot Skills Competition, Galbot competed fully autonomously, with no reliance on teleoperation, setting it apart from most of the 22 teams that depended on human remote control. Galbot excelled at every stage, ranking first in the preliminary, semi-final, and final rounds. Ultimately, it secured the championship with a time of 10 minutes and 22 seconds, scoring a total of 336 points—160 points ahead of the second-place team. The pharmaceutical sorting challenge was particularly intense, simulating real-world medical applications and scenarios. Galbot was tasked with autonomously reading, locating, and picking medications from six multi-tiered shelves, delivering nine correct medications from hundreds to designated containers with top speed and accuracy—all without human assistance. This win is a validation of Galbot's fully autonomous technology, which is already deployed in over 10 smart pharmacies across Beijing, China, with plans to expand to 100+ stores by the end of this year, further demonstrating its potential in real-world healthcare and retail sectors. At the heart of this success is Galbot's unique Sim2Real methodology, which involves massive pre-training on large-scale, high-quality synthetic datasets followed by precise fine-tuning with minimal real-world data. This approach has drastically reduced reliance on costly real-world data collection while enhancing generalizability across diverse environments. Galbot is leading the way in autonomous, general-purpose robotics, bringing cutting-edge AI to every industry. By excelling in complex real-world environments, Galbot is redefining productivity and expanding the possibilities of robotics across every sector. About Galbot Beijing Galbot Co., Ltd. is a global pioneer in embodied AI and general-purpose robotics. Founded in May 2023, Galbot is committed to delivering autonomous, general-purpose robots for global users, with deployments across commercial, industrial, healthcare, and other sectors. Galbot was founded by leading scientists in the field of embodied intelligence. The team has more than a decade of hands-on experience in the robotics industry, having successfully led the mass production of intelligent hardware products at multi-million-unit scale—demonstrating exceptional real-world commercialization capabilities.
Korea Herald
8 hours ago
- Korea Herald
A Decade of Innovation: VAPORESSO Constantly Breaks Through the Infinite Possibilities of Technology
Technology-driven breakthroughs set the tone for VAPORESSO's next decade of industry leadership SHENZHEN, China, Aug. 20, 2025 /PRNewswire/ -- Celebrating its 10th anniversary in 2025, VAPORESSO reflects on a decade of technological breakthroughs that have redefined vaping. With years of innovation and expertise, the brand is introducing a unique, industry-first technology and unveiling a revolutionary advancement that will reshape the novel perception. Building Industry Barriers Through Core Technologies Over the past ten years, VAPORESSO has developed four key technological pillars that form the backbone of its product ecosystem, delivering premium performance and redefining the standards of modern vaping. Groundbreaking Modular Design Unlocks New Dimensions of Tech Innovation After ten years of technological accumulation, VAPORESSO released a groundbreaking innovation, world 1ˢᵗ all-category compatible platform. This transformative modular design, first featured in the latest product – iMate OS, enhances user experience by combining modularity with intelligent adaptability. iMate OS revolutionizes vaping with its innovative magnetic structure, enabling effortless battery separation. The structure tech seamlessly switches between closed and open-system devices while maintaining cross-category compatibility, with its adaptive battery precisely displaying product information for optimal performance. Beyond versatility, it offers unmatched flexibility—users can pair a single battery with multiple pod types, combining the extended battery life of disposable-style devices with the e-liquid customization of open systems. The release and application of this modular design hold positive significance for the vaping industry, setting new standards for innovation, flexibility, and user satisfaction, solidifying VAPORESSO's position as an industry pioneer. Beyond its innovative form design, VAPORESSO will further revolutionize the vaping experience this year by introducing a comprehensive full-scenario solution. We still remember the industry sensation caused by the first-generation COSS. Driven by its smart e-liquid supply system, COSS transformed refilling into a faster, cleaner, and more efficient process. With just one click, COSS could quickly detect remaining e-liquid levels and complete precise refilling within seconds. It was this innovation that earned VAPORESSO the industry's first Golden Leaf Award for Innovation. In Q4 this year, VAPORESSO will launch its next-gen COSS, whose four core evolutionary innovations will redefine premium personalized vaping. Its intelligent auto-refilling system will be enhanced with innovative materials and a redesigned structure, ensuring a seamless and uninterrupted vaping experience. Additionally, enhanced flavor precision, improved battery efficiency, and more ergonomic designs will collectively usher users into a smarter, more refined era of vaping. As VAPORESSO marks its 10th anniversary, its track record of innovation continues to drive the industry forward. With groundbreaking technologies mentioned above, the brand is redefining what's possible in vaping. These advancements not only enhance performance and reliability but also set new standards for user experience. Looking ahead, VAPORESSO's commitment to pushing boundaries ensures it will remain a trailblazer in shaping the future of vaping. For more details, visit
